# OVR Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ovr-health

- Industry: Healthcare
- Headquarters: Austin, US
- Website: www.getrey.com
- Total disclosed funding: $10M
- Latest round: Series A (Jul 30, 2021)
- Investors on record: 2

## About

OVR Health, Inc. is a US-based company specializing in health services, utilizing innovative technology to enhance access to care for consumers through personalized services.Founded in 2020 and headquartered in Austin, Texas, OVR Health, Inc. focuses on improving healthcare access through technology-driven solutions. The company raised USD 10 mn in Series A funding on July 30, 2021, led by investors Optum Ventures and Oxford Sciences Innovation, marking a pivotal moment in its growth strategy. The company's founder has a history of entrepreneurial ventures, although specific prior companies are not detailed.GeTrey.com is a domain name available for sale, offered by HugeDomains, which specializes in acquiring and reselling premium domain names. The core offering is the domain itself, aimed at businesses and individuals seeking to establish an online presence. GeTrey.com caters to entrepreneurs, small and medium enterprises, and digital marketing agencies, facilitating brand visibility and e-commerce capabilities. The domain is marketed globally, serving a diverse customer base across North America, Europe, and Asia.HugeDomains generates revenue through the sale of domain names, including GeTrey.com, which is priced at USD 3,695 or available through flexible payment plans. Customers can purchase domains outright or finance through monthly installments for up to 24 months at 0% interest, making it accessible for various client segments. This model supports businesses in building their online presence without high upfront costs.In July 2021, OVR Health, Inc. raised USD 10 mn in Series A funding to expand its consumer outreach and enhance access to healthcare through personalized services and innovative technology solutions. The company plans to leverage this funding to develop new products aimed at improving healthcare delivery and to target expansion into new geographic markets, though specific regions and timelines for these initiatives have not been disclosed.

## Funding rounds

- Series A, Jul 30, 2021, $10M — Oxford Sciences Enterprises, Optum Ventures

## Investors

- Oxford Sciences Enterprises (https://capitalatlas.ai/funds/oxford-sciences-enterprises) — Series A
- Optum Ventures (https://capitalatlas.ai/funds/optum-ventures) — Series A